Stocks · Health care · Pharmaceutical Preparations

Janux Therapeutics, Inc.

JANX Clue Score43
United States Fiscal year ends December CIK 0001817713 Results filed 5 Nov 2026

What the insiders did Net selling

Insider
Date
Role
Action
Shares
Price
Amount
David Alan Campbell
8 Jul 2026
President and CEO
Exercised, kept
7,000
$4.21
$29.47K
Janeen Noel Doyle
2 Jun 2026
Chief Corp. & Bus. Dev. Ofcr
Sell
4,059
$14.03
$56.94K
Maria Dobek
11 May 2026
Vice President, Accounting
Sell
2,038
$14.17
$28.88K
Maria Dobek
2 Jan 2026
Vice President, Accounting
Sell
1,462
$13.73
$20.07K
Zachariah McIver
2 Jan 2026
Chief Medical Officer
Sell
2,714
$13.73
$37.26K
Charles M. Winter
2 Jan 2026
Chief Technical Officer
Sell
2,401
$13.73
$32.97K
David Alan Campbell
2 Jan 2026
President and CEO
Sell
8,072
$13.73
$110.83K
Thomas DiRaimondo
2 Jan 2026
Chief Scientific Officer
Sell
2,505
$13.73
$34.39K
Andrew Hollman Meyer
2 Jan 2026
Chief Business Officer
Sell
1,879
$13.73
$25.80K
Andrew Hollman Meyer
1 Dec 2025
Chief Business Officer
Sold after exercise
633
$33.52
$21.22K
Andrew Hollman Meyer
1 Dec 2025
Chief Business Officer
Sold after exercise
2,700
$32.85
$88.71K
Andrew Hollman Meyer
14 Nov 2025
Chief Business Officer
Sold after exercise
3,333
$30.00
$99.99K
Andrew Hollman Meyer
28 Oct 2025
Chief Business Officer
Sold after exercise
16,665
$30.06
$500.99K
Andrew Hollman Meyer
1 May 2025
Chief Business Officer
Sold after exercise
400
$32.60
$13.04K
Andrew Hollman Meyer
1 May 2025
Chief Business Officer
Sold after exercise
2,933
$31.95
$93.70K
Andrew Hollman Meyer
21 Apr 2025
Chief Business Officer
Sold after exercise
3,334
$30.00
$100.02K
Ra Capital Management, L.p.
7 Mar 2025
Director
Buy indirect
110,206
$31.02
$3.42M
Ra Capital Management, L.p.
6 Mar 2025
Director
Buy indirect
372,093
$30.78
$11.45M
Ra Capital Management, L.p.
5 Mar 2025
Director
Buy indirect
37,455
$31.30
$1.17M
Ra Capital Management, L.p.
5 Mar 2025
Director
Buy indirect
304,287
$30.56
$9.30M
Andrew Hollman Meyer
3 Mar 2025
Chief Business Officer
Sold after exercise
901
$32.85
$29.60K
Andrew Hollman Meyer
3 Mar 2025
Chief Business Officer
Sold after exercise
2,433
$31.88
$77.58K
Andrew Hollman Meyer
3 Feb 2025
Chief Business Officer
Sold after exercise
100
$43.60
$4.36K
Andrew Hollman Meyer
3 Feb 2025
Chief Business Officer
Sold after exercise
816
$42.77
$34.90K
Andrew Hollman Meyer
3 Feb 2025
Chief Business Officer
Sold after exercise
2,418
$42.08
$101.74K
David Alan Campbell
7 Jan 2025
President and CEO
Sold on a plan
5,000
$60.00
$300.00K
Andrew Hollman Meyer
2 Jan 2025
Chief Business Officer
Sell
200
$57.37
$11.47K
Andrew Hollman Meyer
2 Jan 2025
Chief Business Officer
Sell
1,000
$56.78
$56.78K
Andrew Hollman Meyer
2 Jan 2025
Chief Business Officer
Sell
3,444
$55.76
$192.03K
Andrew Hollman Meyer
2 Jan 2025
Chief Business Officer
Sell
5,768
$54.51
$314.42K
Andrew Hollman Meyer
2 Jan 2025
Chief Business Officer
Sell
2,922
$53.76
$157.08K
David Alan Campbell
24 Dec 2024
President and CEO
Sold on a plan
25,000
$56.19
$1.40M
Andrew Hollman Meyer
19 Dec 2024
Chief Business Officer
Exercised, kept
1
$14.02
$14.02
Andrew Hollman Meyer
19 Dec 2024
Chief Business Officer
Exercised, kept
9,880
$20.24
$199.97K
David Alan Campbell
3 Dec 2024
President and CEO
Sold on a plan
15,000
$67.00
$1.01M
David Alan Campbell
25 Nov 2024
President and CEO
Sold on a plan
6,719
$52.04
$349.65K
David Alan Campbell
25 Nov 2024
President and CEO
Sold on a plan
18,281
$51.43
$940.23K
David Alan Campbell
28 Oct 2024
President and CEO
Sold on a plan
11,103
$53.94
$598.91K
David Alan Campbell
28 Oct 2024
President and CEO
Sold on a plan
13,897
$53.22
$739.65K
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell indirect
553,219
$44.75
$24.76M
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell indirect
104,957
$44.75
$4.70M
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell
541,824
$44.75
$24.25M
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell indirect
15,788
$51.18
$808.03K
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell indirect
2,995
$51.18
$153.28K
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell
15,462
$51.18
$791.35K
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell indirect
104,892
$50.30
$5.28M
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell indirect
19,900
$50.30
$1.00M
Avalon Ventures XI, L.P.
18 Oct 2024
10% owner
Sell
102,732
$50.30
$5.17M
Ra Capital Management, L.p.
18 Oct 2024
Director
Buy indirect
1,200,000
$44.75
$53.70M
Avalon Ventures XI, L.P.
17 Oct 2024
10% owner
Sold after exercise
1,843
$50.02
$92.19K
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise
10,957
$50.80
$556.62K
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise indirect
30,094
$50.61
$1.52M
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise indirect
5,710
$50.61
$288.98K
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise
29,474
$50.61
$1.49M
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise indirect
61,445
$49.69
$3.05M
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise indirect
11,657
$49.69
$579.24K
Avalon Ventures XI, L.P.
16 Oct 2024
10% owner
Sold after exercise
60,179
$49.69
$2.99M
Avalon Ventures XI, L.P.
30 Sep 2024
10% owner
Sold after exercise
958
$46.24
$44.30K
David Alan Campbell
27 Sep 2024
President and CEO
Sold on a plan
795
$47.84
$38.03K
David Alan Campbell
27 Sep 2024
President and CEO
Sold on a plan
5,248
$46.86
$245.90K
David Alan Campbell
27 Sep 2024
President and CEO
Sold on a plan
18,957
$46.09
$873.71K
Thomas DiRaimondo
27 Sep 2024
Chief Scientific Officer
Sold on a plan
675
$47.22
$31.88K
Thomas DiRaimondo
27 Sep 2024
Chief Scientific Officer
Sold on a plan
4,325
$46.21
$199.84K
Andrew Hollman Meyer
27 Sep 2024
Chief Business Officer
Sold after exercise
50,000
$45.96
$2.30M
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise
1,826
$46.19
$84.34K
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise indirect
1,542
$47.74
$73.62K
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise indirect
293
$47.74
$13.99K
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise
1,511
$47.74
$72.14K
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise indirect
46,861
$46.42
$2.18M
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise indirect
8,894
$46.42
$412.86K
Avalon Ventures XI, L.P.
27 Sep 2024
10% owner
Sold after exercise
45,894
$46.42
$2.13M
Avalon Ventures XI, L.P.
26 Sep 2024
10% owner
Sell indirect
41,661
$47.77
$1.99M
Avalon Ventures XI, L.P.
26 Sep 2024
10% owner
Sell indirect
7,908
$47.77
$377.77K
Avalon Ventures XI, L.P.
26 Sep 2024
10% owner
Sell
40,803
$47.77
$1.95M
Avalon Ventures XI, L.P.
26 Sep 2024
10% owner
Sell indirect
50,539
$46.78
$2.36M
Avalon Ventures XI, L.P.
26 Sep 2024
10% owner
Sell indirect
9,592
$46.78
$448.71K
Avalon Ventures XI, L.P.
26 Sep 2024
10% owner
Sell
49,497
$46.78
$2.32M
Jay Lichter
13 Sep 2024
10% owner
Sold after exercise
3,815
$46.68
$178.08K
Avalon Ventures XI, L.P.
12 Sep 2024
10% owner
Sell indirect
161,356
$47.00
$7.58M
Avalon Ventures XI, L.P.
12 Sep 2024
10% owner
Sell indirect
30,613
$47.00
$1.44M
Avalon Ventures XI, L.P.
12 Sep 2024
10% owner
Sell
158,031
$47.00
$7.43M
Avalon Ventures XI, L.P.
10 Sep 2024
10% owner
Sell indirect
35,047
$46.66
$1.64M
Avalon Ventures XI, L.P.
10 Sep 2024
10% owner
Sell indirect
6,649
$46.66
$310.24K
Avalon Ventures XI, L.P.
10 Sep 2024
10% owner
Sell
34,326
$46.66
$1.60M
Avalon Ventures XI, L.P.
10 Sep 2024
10% owner
Sell indirect
11,557
$46.13
$533.12K
Avalon Ventures XI, L.P.
10 Sep 2024
10% owner
Sell indirect
2,193
$46.13
$101.16K
Avalon Ventures XI, L.P.
10 Sep 2024
10% owner
Sell
11,319
$46.13
$522.15K
Avalon Ventures XI, L.P.
9 Sep 2024
10% owner
Sold after exercise
2,182
$42.33
$92.36K
Avalon Ventures XI, L.P.
6 Sep 2024
10% owner
Sell indirect
110,644
$42.00
$4.65M
Avalon Ventures XI, L.P.
6 Sep 2024
10% owner
Sell indirect
20,991
$42.00
$881.62K
Avalon Ventures XI, L.P.
6 Sep 2024
10% owner
Sell
108,365
$42.00
$4.55M
Avalon Ventures XI, L.P.
3 Jun 2024
10% owner
Sell indirect
691,525
$54.75
$37.86M
Avalon Ventures XI, L.P.
3 Jun 2024
10% owner
Sell indirect
131,196
$54.75
$7.18M
Avalon Ventures XI, L.P.
3 Jun 2024
10% owner
Sell
677,279
$54.75
$37.08M
Tighe Reardon
3 Jun 2024
Acting Chief Financial Officer
Sell indirect
691,525
$54.75
$37.86M
Tighe Reardon
3 Jun 2024
Acting Chief Financial Officer
Sell indirect
131,196
$54.75
$7.18M
Jay Lichter
3 Jun 2024
Director
Sell indirect
691,525
$54.75
$37.86M
Jay Lichter
3 Jun 2024
Director
Sell indirect
131,196
$54.75
$7.18M
Jay Lichter
3 Jun 2024
Director
Sell indirect
677,279
$54.75
$37.08M
Avalon Ventures XI, L.P.
13 Nov 2023
10% owner
Buy indirect
849,854
$5.87
$4.99M
Jay Lichter
13 Nov 2023
Director
Buy indirect
849,854
$5.87
$4.99M
Tighe Reardon
13 Nov 2023
Acting Chief Financial Officer
Buy indirect
849,854
$5.87
$4.99M
Ra Capital Management, L.p.
19 Jul 2023
Director
Buy indirect
495,008
$12.46
$6.17M
Peter A. Thompson
29 Dec 2021
Director
Sell indirect
3,700
$20.30
$75.11K
Peter A. Thompson
29 Dec 2021
Director
Sell indirect
36,700
$20.30
$745.01K
Orbimed Advisors LLC
29 Dec 2021
Director
Sell indirect
3,700
$20.30
$75.11K
Orbimed Advisors LLC
29 Dec 2021
Director
Sell indirect
36,700
$20.30
$745.01K
Peter A. Thompson
21 Dec 2021
Director
Sell indirect
11,100
$19.00
$210.90K
Peter A. Thompson
21 Dec 2021
Director
Sell indirect
108,300
$19.00
$2.06M
Orbimed Advisors LLC
21 Dec 2021
Director
Sell indirect
11,100
$19.00
$210.90K
Orbimed Advisors LLC
21 Dec 2021
Director
Sell indirect
108,300
$19.00
$2.06M
Orbimed Advisors LLC
16 Dec 2021
Director
Sell indirect
36,500
$19.07
$696.06K
Orbimed Advisors LLC
16 Dec 2021
Director
Sell indirect
356,800
$19.07
$6.80M
Peter A. Thompson
16 Dec 2021
Director
Sell indirect
36,500
$19.07
$696.06K
Peter A. Thompson
16 Dec 2021
Director
Sell indirect
356,800
$19.07
$6.80M
Ra Capital Management, L.p.
15 Jun 2021
Director
Buy indirect
188,986
$17.00
$3.21M
Ra Capital Management, L.p.
15 Jun 2021
Director
Buy indirect
2,752,190
$17.00
$46.79M
Avalon Ventures XI, L.P.
15 Jun 2021
10% owner
Buy indirect
629,411
$17.00
$10.70M
Jay Lichter
15 Jun 2021
Director
Buy indirect
629,411
$17.00
$10.70M
Tighe Reardon
15 Jun 2021
Acting Chief Financial Officer
Buy indirect
629,411
$17.00
$10.70M
Orbimed Advisors LLC
15 Jun 2021
Director
Buy indirect
117,650
$17.00
$2.00M
Orbimed Advisors LLC
15 Jun 2021
Director
Buy indirect
588,203
$17.00
$10.00M
Peter A. Thompson
15 Jun 2021
Director
Buy indirect
117,650
$17.00
$2.00M
Peter A. Thompson
15 Jun 2021
Director
Buy indirect
588,203
$17.00
$10.00M
Bregua Corp
15 Jun 2021
10% owner
Buy
58,823
$17.00
$999.99K

What was left out

Form 4 filings counted 136
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 22
Sales on a Rule 10b5-1 plan 12
Sales straight out of an exercise 31
Sales at will 60
Transactions with no price 0
Shares from compensation/vesting 36,004,274
Sales filed before the plan box existed 12
History held since 14 Jun 2021